Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis

To prevent recurrent venous thrombotic events after acute cerebral venous or dural sinus thrombosis, guidelines recommend long-term oral anticoagulation with vitamin K antagonists. Non-vitamin K oral anticoagulant experience in cerebral venous or dural sinus thrombosis is limited to case reports and series.

I’m Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke and I spoke with Professor Jose Ferro from University of Lisbon – Neurology Hospital Santa Maria, Lisbon, Portugal.

The International Journal of Stroke is the flagship publication of the World Stroke Organization - please consider becoming a member, you can find links to membership in the text of this podcast or at www.world-stroke.com  

Music is Kool Kats by Kevin MacLeod 

https://wso.multiregistration.com

https://www.world-stroke.org/membership/membership-zone

Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients  with cerebral venous thrombosis  SAGE LINK